UK Cancer Drugs Fund: NHS England has agreed to... - CLL Support

CLL Support

23,088 members39,649 posts

UK Cancer Drugs Fund

MaudMarie profile image
7 Replies

NHS England has agreed to increase the annual Cancer Drugs Fund by 40%.

This is a recognition of the need to enable cancer patients to access new and innovative therapies.

The letter from the CEO of NHS England to the Chair of the Cancer Drugs Fund is on the NHS website. england.nhs.uk/ news article dates 28 August 2014.

I hope that some of the lobbying by CLLSA patients in the UK has contributed to this decision. There is much more to do.

Written by
MaudMarie profile image
MaudMarie
To view profiles and participate in discussions please or .
7 Replies
Newdawn profile image
NewdawnAdministrator

Yes it's good news indeed MaudMarie. I posted earlier on the subject on this thread. Dick's response to it is very interesting. I hope that collective pressure from all affected by cancer has contributed to the decision but as you say there's so much more to do.

healthunlocked.com/cllsuppo...

Newdawn

MaudMarie profile image
MaudMarie in reply to Newdawn

Thanks Newdawn. I believe that both Ibrutinib and Idelalisib have been put forward to the CDF committee for review. Although the drugs have been approved by the European Drugs Agency it will be many months before we know whether they will be put forward to NICE for a full appraisal by the Secretary of State for Health. CDF could provide a helpful interim step but there is no guarantee at this stage that these drugs will get on the list.

Meanwhile patients needing treatment should talk to their haematologists about the new trials using some of the novel innovative therapies that are starting up in England. More information on this is coming soon.

Kwenda profile image
Kwenda in reply to MaudMarie

Link to newer page on the BBC website..

healthunlocked.com/cllsuppo...

One can only hope this will include NHS Wales and Scotlan and N. I.

Does anyone know?

Haileybury profile image
Haileybury

It's very encouraging and for me personally. My FCR was halted after two courses as my neutrophils have always been a problem and have now reached 0.5. More problematic is that I have severe pleural effusions since starting chemotherapy. My local haematologist consultant has had approval from Dr Anna Schuh in Oxford to be assessed there with a view to me getting Ibrutinib on compassionate grounds or maybe getting on to a trial. Fingers crossed.

David.

MaudMarie profile image
MaudMarie in reply to Haileybury

Hurry David as the Ibrutinib Compassionate access Programme ends in September. Janssen call it a Named Person Access Programme. The trial IciCLLe is Ibrutinib only.

Best wishes and good luck.

Haileybury profile image
Haileybury in reply to MaudMarie

Great news. I'm collecting my ibrutinib from Oxford on Monday. Dr Schuh has agreed that I qualify on the named person access. My wife and I are so relieved that I can now resume treatment but on this "wonder drug".

David.

Not what you're looking for?

You may also like...

Petition to safeguard the England Cancer Drugs Fund (UK)

Hullo All, My Haemotologist recently set up a petition to ask the government to reverse the recent...

Bloodwise news

Blood cancer drugs kept on the Cancer Drugs Fund We're delighted to announce that NHS England have...

Positive & negative results for CLL treatments following the latest round of reviews by the National Cancer Drugs Fund

Mixed results FOR CLL treatments availble through the CDF as the final verdict following the...

CLLSA Response to NHS England Failing to Fund Ibrutinib in line with NICE Guidance

Many of you will have seen the articles in The Times this weekend which have revealed an issue of...

Cancer Lottery - campaign asking for fair consideration of new drugs required to treat rarer cancer patients in the UK

Many will have been following the unsatisfactory way in which new drugs for CLL are being assessed...